ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Is a Good Night's Sleep at the Top of Your Wishlist?

Ashwagandha Helps Hormones - Aids Arthritis

Why You Should Be Eating More Porcini Mushrooms

A Breathalyzer for Disease?

How Bacopa Can Help Improve Your Cognitive Function

Magnesium Reduces Diabetes and Helps Keep You Young

Lavender Aromatherapy Can Ease Pre-Op Anxiety

Give Your Health a Much-Needed Boost With Geranium

The Role of Resveratrol in Achieving Optimal Health

Could Coconut Oil Help Reduce Antibiotics?

 
Print Page
Email Article

Problem elicitation to assess patient priorities in ankylosing spondylitis & fibromyalgia (FM)

  [ 36 votes ]   [ Discuss This Article ]
www.ProHealth.com • July 10, 1996


OBJECTIVE. To elicit patient priorities as outcome measures in
ankylosing spondylitis (AS) and fibromyalgia (FM); to relate
these measures to other outcomes; to assess construct validity
and sensitivity to change of the problem elicitation technique
(PET) questionnaire.

METHODS. One hundred thirty-four patients
with AS were randomly allocated to weekly sessions of group
physical therapy or daily exercises at home, whereas 73
patients with FM were randomized into one of 3 groups (low
impact fitness, biofeedback, controls). The PET questionnaire
was applied by trained interviewers at baseline and at 6 (FM)
and 9 (AS) month followup. A PET score was calculated at each
assessment. Construct validity of the PET was assessed by
correlation and multiple regression of baseline values with
other disease outcomes (pain, stiffness, patient's global
assessment, Sickness Impact Profile (SIP), Health Assessment
Questionnaire (HAQ), Arthritis Impact Measurement Scale
(AIMS), patient utilities). Sensitivity to change of PET was
assessed against changes in these outcomes and by comparing
the efficiency of the PET with other outcomes.

RESULTS.
Patients with FM identified more problems (mean 6.8) than
patients with AS (mean 4.4). Moreover, more patients with AS
than with FM were unable to identify any problem at baseline
(10% compared to 1%). The PET score improved from 14.9 to 11.3
(p = 0.0001) in patients with AS but did not change from 21.8
to 21.1 (p = 0.24) in patients with FM. Construct validity
testing of the PET score showed statistically significant (p <
0.05) correlations with AIMS, utilities, SIP, HAQ, pain,
stiffness, and patient's global health in both groups of
patients (r varying from 0.22 to 0.66). By multiple regression
pain explained 29% of the variance in PET scores among
patients with AS. In FM patient global assessment accounted
for 39% of total variance of PET scores, whereas pain
explained another 15%. Changes in PET scores correlated
significantly (p < 0.05) with changes in AIMS, utilities,
pain, stiffness, and patient global health in both AS and FM
(r varying from 0.22 to 0.51). Some 6% of the variance in
changes in PET scores was explained by changes in pain in
patients with AS and 35% by changes in pain and subjective
health in patients with FM. Assessment of sensitivity to
change revealed that efficiency of the PET score was 0.6 in
patients with AS and 0.09 in those with FM. Compared to other
outcomes this was reasonable in patients with AS but low in
those with FM.

CONCLUSION. Obtaining patient priorities was
generally feasible. In both groups of patients construct
validity of the PET questionnaire was satisfactory. The PET
was much more sensitive to change in patients with AS than in
patients with FM.

Bakker C, van der Linden S, van Santen-Hoeufft M, Bolwijn P, Hidding
A




Post a Comment

Featured Products From the ProHealth Store
FibroSleep™ Energy NADH™ 12.5mg Optimized Curcumin Longvida®


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health
The Super Antioxidant for Brain, Joint and Heart Health The Super Antioxidant for Brain, Joint and Heart Health
Bone Broth Benefits for Digestion, Arthritis and Cellulite Bone Broth Benefits for Digestion, Arthritis and Cellulite
Probiotic Mint Promotes Healthy Gums & Teeth, Freshens Breath and Whitens Teeth Probiotic Mint Promotes Healthy Gums & Teeth, Freshens Breath and Whitens Teeth
More Weight Loss than Any Other Discovery in Supplement History More Weight Loss than Any Other Discovery in Supplement History

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map